2024-03-18T12:49:44-05:00 2023-06-30 FORVIS LLP 1155 Avenue of the Americas 1200 New York NY 10036 990 2022-07-01 330841281 PANCREATIC CANCER ACTION NETWORK INC % SUZANNE NEUMAN PANC 3107250025 1500 ROSECRANS AVENUE Suite 200 MANHATTAN BEACH CA 90266 ANAT KENDAL CHIEF FINANCIAL OFFI 5624351191 2024-01-15 true ANAT KENDAL 999009999 Aaron Shapiro P01333816 2128674000 3 2022 2023-04-26 12:10:37Z JULIE FLESHMAN 1500 ROSECRANS AVENUE MANHATTAN BEACH CA 90266 101498999 false X WWW.PANCAN.ORG X 1999 CA TO ADVANCE RESEARCH, SUPPORT PATIENTS, AND CREATE HOPE FOR PEOPLE WHO HAVE PANCREATIC CANCER. 15 14 214 2100 0 45401251 65007979 7241610 16312934 1332466 -381186 -3281201 -3379310 50694126 77560417 10191634 6479366 0 0 22161066 27153984 0 0 6411608 22179705 36080342 54532405 69713692 -3838279 7846725 65833440 80600372 26967968 31779936 38865472 48820436 X OUR MISSION IS TO TAKE BOLD ACTION TO IMPROVE THE LIVES OF EVERYONE IMPACTED BY PANCREATIC CANCER BY ADVANCING SCIENTIFIC RESEARCH, BUILDING COMMUNITY, SHARING KNOWLEDGE, AND ADVOCATING FOR PATIENTS. false false 37566422 6479366 16334057 RESEARCH - PANCAN FUNDS GROUNDBREAKING RESEARCH INITIATIVES THAT WILL TRANSFORM THE WAY PANCREATIC CANCER IS DETECTED AND TREATED. WE FUND RESEARCH GRANTS TO INDIVIDUAL INVESTIGATORS AND LARGE-SCALE, MULTI-INSTITUTIONAL CLINICAL PROJECTS THAT ARE FOCUSED ON ADVANCING NEW TREATMENTS AND EARLY DETECTION FOR PANCREATIC CANCER. WE INVESTED A RECORD $34.4 MILLION IN RESEARCH IN FISCAL YEAR 2023. RESEARCH FUNDING THAT SUPPORTED IMPORTANT RESEARCH PROJECTS AT INSTITUTIONS ACROSS THE COUNTRY, AND PANCAN'S PRECISION PROMISE ADAPTIVE CLINICAL TRIAL, EARLY DETECTION INITIATIVE, KNOW YOUR TUMOR PRECISION MEDICINE SERVICE, AND PATIENT REGISTRY. SINCE 2003 PANCAN HAS AWARDED 236 RESEARCH GRANTS TO 217 SCIENTISTS AT 78 INSTITUTIONS. PANCAN'S CUMULATIVE RESEARCH INVESTMENT IS NOW MORE THAN $208 MILLION, MAKING A SIGNIFICANT IMPACT ON THE DIAGNOSIS, TREATMENT AND CARE OF TODAY'S PATIENTS AND THOSE WHO WILL BE DIAGNOSED IN THE FUTURE. 8686456 COMMUNITY ENGAGEMENT - NEARLY 60 VOLUNTEER-LED AFFILIATES WITH MORE THAN 2,100 VOLUNTEERS RAISE AWARENESS OF PANCAN AND THE DISEASE AND EDUCATE THEIR COMMUNITIES ABOUT PANCREATIC CANCER. VOLUNTEERS HOSTED 60 PURPLESTRIDE EVENTS ACROSS THE COUNTRY THIS PAST YEAR, MORE THAN 61,000 PARTICIPANTS REGISTERED SUPPORTING SURVIVORS, FAMILIES AND FRIENDS, AS WELL AS PROVIDING EDUCATIONAL INFORMATION AT THE EVENTS. PURPLESTRIDE PARTICIPANTS RAISED MORE THAN $17 MILLION IN FISCAL YEAR 2023. WE ARE ALSO A FOUNDING MEMBER OF THE WORLD PANCREATIC CANCER COALITION, COMPRISING MORE THAN 100 PANCREATIC CANCER PATIENT ADVOCACY GROUPS FROM MORE THAN 30 COUNTRIES AND SIX CONTINENTS. THE COALITION HOSTS WORLD PANCREATIC CANCER DAY EVERY NOVEMBER TO RAISE GLOBAL AWARENESS OF THE DISEASE. 4256510 PATIENT SERVICES - PROVIDES FREE, PERSONALIZED INFORMATION AND RESOURCES ABOUT PANCREATIC CANCER, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP PATIENTS, CAREGIVERS AND HEALTHCARE PROVIDERS. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE CONSTITUTENTS WITH PERSONALIZED SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR EXPERT PATIENT SERVICES CASE MANAGERS SHARE MORE RESOURCES AND SPEAK WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER ORGANIZATION IN THE WORLD. LAST YEAR ALONE, WE HAD NEARLY 60,000 INTERACTIONS WITH PANCREATIC CANCER PATIENTS AND FAMILIES. 1512398 52021786 true true false true false false false false false false true false false false true true true false false false false false false false true false false true false true false false false false false false false false true false false false false false false false false true 72 0 true 214 true false false false false false false false false false false false false X 15 14 false false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X SUZANNE NEUMAN 3107250025 1500 ROSECRANS AVENUE 200 MANHATTAN BEACH CA 90266 Julie Fleshman President & CEO/Director 50.0 0.0 X X 658541 0 61834 SUDHEER DOSS CHIEF BUSINESS OFFICER 50.0 0.0 X 417839 0 35568 Anat Kendal Chief Financial Officer 50.0 0.0 X 356349 0 30459 LYNN MATRISIAN CHIEF SCIENCE OFFICER 50.0 0.0 X 358162 0 25443 JODI LIPE CHIEF MARKETING AND COMMUNICAT 50.0 0.0 X 323918 0 41833 EDWINA MOSSETT CHIEF PEOPLE OFFICER 50.0 0.0 X 337272 0 19738 LORI STEVENS CHIEF DEV. OFFICER thru 3/2023 50.0 0.0 X 316792 0 37328 LISA GRAY SENIOR VICE PRESIDENT, DEVELOP 50.0 0.0 X 298956 0 23169 ANNE-MARIE DULIEGE CHIEF MED. OFFICER thru 3/2022 50.0 0.0 X 286092 0 5921 MICHAEL AG KORENGOLD Chairman 2.0 0.0 X X 0 0 0 KAREN YOUNG CPA VICE CHAIRMAN 2.0 0.0 X X 0 0 0 MARCO ARGENTI BOARD MEMBER 2.0 0.0 X 0 0 0 PETER CASHION BOARD MEMBER 2.0 0.0 X 0 0 0 DENNIS CRONIN BOARD MEMBER 2.0 0.0 X 0 0 0 BARBARA J KENNER PHD BOARD MEMBER 2.0 0.0 X 0 0 0 HILARIE KOPLOW-MC ADAMS BOARD MEMBER 2.0 0.0 X 0 0 0 JASON KUHN BOARD MEMBER 2.0 0.0 X 0 0 0 LISA KULOK BOARD MEMBER 2.0 0.0 X 0 0 0 CRAIG A ROGERSON BOARD MEMBER 2.0 0.0 X 0 0 0 NANCY STAGLIANO PHD BOARD MEMBER 2.0 0.0 X 0 0 0 KARYN A TEMPLE BOARD MEMBER 2.0 0.0 X 0 0 0 ROD WILLIAMS MBA BOARD MEMBER 2.0 0.0 X 0 0 0 LINDA AMUSO BOARD MEMBER 2.0 0.0 X 0 0 0 3353921 0 281293 70 true true false MEDIA STORM LLC PO BOX 6411 BRATTLEBORO VT 05302 ADVERTISING 1644272 Motion 5015 Arden Avenue EDINA MN 55424 Video Production 728591 Berry Consultants LLC 3345 Bee Caves Rd Suite 201 AUSTIN TX 78746 Consulting Services 489252 RSM US LLP 5155 Paysphere Circle CHICAGO IL 60674 Accounting 185456 Native Marketing 128 Windsor Road ASHEVILLE NC 28804 Marketing 164889 7 17192584 47815395 369976 65007979 CLINICAL RESEARCH CONTRACTS 541700 16312934 16312934 16312934 1368795 1368795 0 0 0 0 0 18760106 20510087 -1749981 -1749981 -1749981 0 17192584 3400433 -3400433 -3400433 0 0 0 49185 28062 21123 21123 0 77560417 16334057 -3781619 6479366 6479366 0 0 0 2013079 1173887 520875 318317 0 21024986 12260299 5440119 3324568 657480 398617 150473 108390 1953210 1181349 450688 321173 1505229 909176 348901 247152 0 76616 45970 30646 94213 56528 37685 252214 252214 0 176013 176013 27503705 25380856 993011 1129838 1778503 1492220 58495 227788 366397 229553 83992 52852 1653243 395527 869171 388545 0 1070601 621830 281609 167162 0 0 910517 697570 152709 60238 0 0 243246 179040 37432 26774 349510 146300 203210 FINANCE & PROCESSING CHARGES 1437416 1437416 DONOR AND AFFILIATE ENGAGEMENT 168148 121484 7853 38811 69713692 52021786 11280298 6411608 7737919 5515743 13890504 2333795 8249392 22972929 4413423 9244571 0 0 0 0 0 0 40327 30293 829383 3594841 5840284 5506989 501515 333295 29948473 33467132 0 0 0 0 0 0 222504 3107773 65833440 80600372 11973537 14184544 12349632 13015778 1869944 1074901 0 0 0 0 0 0 0 0 0 0 774855 3504713 26967968 31779936 X 31481468 24894185 7384004 23926251 38865472 48820436 65833440 80600372 7846725 2108239 X false true X true false X 41998701 35529596 36292699 45222545 65007979 224051520 0 0 41998701 35529596 36292699 45222545 65007979 224051520 22735564 201315956 887064 907982 697700 1176978 1368795 5038519 0 450 20400 20850 229110889 35491736 0.87868 0.86910 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 105426 146788 252214 66289922 66542136 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 98429 268448 314265 252214 933356 250000 250000 250000 250000 1000000 1500000 4939 109672 120132 105426 340169 SCHEDULE C, PART II-A PANCAN ENGAGES IN DEVELOPING REPORT LANGUAGE FOR APPROPRIATIONS BILLS; DEVELOPING ALERTS TO OUR MEMBERS REGARDING SPECIFIC LEGISLATION; PREPARING FOR AND ATTENDING VISITS ON CAPITAL HILL BY OUR MEMBERS AND THE PUBLIC DURING ADVOCACY DAYS BOTH IN PERSON AND VIRTUALLY; GIVING UNINVITED AND INVITED TESTIMONY OR WRITTEN RESPONSES DURING LEGISLATIVE HEARINGS; AND DEVELOPING GENERAL EDUCATION MESSAGES THROUGH MEDIA CAMPAIGNS THAT DO OR DO NOT INCLUDE A CALL FOR ACTION. 895054 866015 29039 1566532 1343807 222725 3378698 3297167 81531 333295 0 LEASE OBLIGATIONS 3504713 3504713 X 79615143 2108239 122500 2230739 77384404 176013 176013 77560417 69660179 122500 122500 69537679 176013 176013 69713692 Schedule D, Part X, Line 2 Management has evaluated their income tax positions under the guidance included in ASC 740. Based on their review, management has not identified any material uncertain tax positions to be recorded or disclosed in the financial statements. PURPLE STRIDE 17192584 17192584 5047 1565812 11694 87956 1729924 0 17192584 17192584 5047 1565812 11694 87956 1729924 3400433 -3400433 SCHEDULE G, PART I, LINE 3 THE ORGANIZATION IS REGISTERED TO FUNDRAISE IN EVERY STATE. IN FISCAL YEAR 2023, THE PROPER STATE REGISTRATION FORMS WERE FILED. true MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02145 042697983 501(C)(3) 250000 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 042263040 501(C)(3) 400000 RESEARCH REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITI 450 MCNAMARA ALUMNI CENTER 200 OAK MINNEAPOLIS MN 55455 416007513 170(C)(1) 250000 RESEARCH GEORGETOWN UNIVERSITY 37TH AND O STREETS NW WASHINGTON DC 20057 530196603 501(C)(3) 250000 RESEARCH THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF BOX 49 630 WEST 168TH STREET NEW YORK NY 10032 135598093 501(C)(3) 177000 RESEARCH UNIVERSITY OF CHICAGO 29 EAST 57TH STREET CHICAGO IL 60637 362177139 501(C)(3) 150000 RESEARCH SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP 100 SOUTH LOS ROBLES AVENUE 2ND FL PASADENA CA 91101 951750445 225000 RESEARCH 5 2 PART I, LINE 2 THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS RESEARCH GRANTS PROGRAM IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGIBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC LEADERSHIP IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS, GRANT RESTRICTIONS (INCLUDING USE OF FUNDS) AND REPORTING PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED. THESE PROGRESS REPORTS ARE COLLECTED AND REVIEWED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. PROGRAM STAFF COMMUNICATE DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. THE PANCREATIC CANCER ACTION NETWORK HAS ESTABLISHED OTHER GRANT AGREEMENTS TO FUND SCIENTIFIC INITIATIVES IN CLINICAL TRIALS RESEARCH AND EARLY DETECTION OF PANCREATIC CANCER. X X X X X X true true false true false false false false false Julie Fleshman President & CEO/Director 532341 0 126200 0 0 0 32700 0 29134 0 720375 0 Anat Kendal Chief Financial Officer 305405 0 42000 0 8944 0 12200 0 18259 0 386808 0 EDWINA MOSSETT CHIEF PEOPLE OFFICER 292282 0 42000 0 2990 0 12200 0 7538 0 357010 0 JODI LIPE CHIEF MARKETING AND COMMUNICAT 281918 0 42000 0 0 0 12200 0 29633 0 365751 0 LISA GRAY SENIOR VICE PRESIDENT, DEVELOP 269556 0 29400 0 0 0 10606 0 12563 0 322125 0 LORI STEVENS CHIEF DEV. OFFICER thru 3/2023 234792 0 42000 0 40000 0 11147 0 26181 0 354120 0 ANNE-MARIE DULIEGE CHIEF MED. OFFICER thru 3/2022 87602 0 0 0 198490 0 3090 0 2831 0 292013 0 SUDHEER DOSS CHIEF BUSINESS OFFICER 345839 0 72000 0 0 0 12200 0 23368 0 453407 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 295662 0 42000 0 20500 0 12200 0 13243 0 383605 0 PART I, LINE 4A The following individual received a severance payment during the calendar year ended December 31, 2022: Anne-Marie Duliege $180,000 PART I, LINE 4B THE FOLLOWING INDIVIDUAL PARTICIPATES IN A NON-QUALIFIED TAXABLE RETIREMENT PLAN OF THE ORGANIZATION. THE AMOUNT SHOWN REPRESENTS THE ORGANIZATION'S EMPLOYER CONTRIBUTION TO THE PLAN FOR THE YEAR ENDED JUNE 30, 2023: JULIE FLESHMAN $20,500 part I line 5 THE PERFORMANCE INCENTIVE PLAN REWARDS OUR VALUED TEAM MEMBERS IF CERTAIN REVENUE GOALS ARE REACHED. X 47 369526 FMV X 3 450 FMV false true false SCHEDULE M, PART I, COLUMN (B) THE AMOUNT IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION'S AUDIT AND INVESTMENT COMMITTEE (AIC) RECEIVES AND REVIEWS THE DRAFT OF THE FORM 990, INCLUDING SCHEDULES, PRIOR TO THE FILING OF THE RETURN. A MEETING OF THE AIC, INCLUDING THE PRESIDENT AND CEO, VP OF FINANCE, THE CFO, THE CONTROLLER, AND THE OUTSIDE CPA FIRM, IS THEN HELD TO REVIEW AND REVISE THE DRAFT OF THE FORM 990 AS NECESSARY. UPON APPROVAL OF THE DRAFT FORM 990 BY THE AIC, THE FINAL FORM 990, WITH CHANGES REFLECTED, IF ANY, IS E-MAILED TO THE ENTIRE BOARD OF DIRECTORS FOR REVIEW PRIOR TO FILING. UPON BOARD APPROVAL, THE FINAL FORM 990 IS FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT AN UPDATED CONFLICT OF INTEREST STATEMENT ANNUALLY. TO THE EXTENT THAT RELATIONSHIPS ARE IDENTIFIED VIA THESE STATEMENTS AND OTHER INFORMATION, THE INDIVIDUAL'S CONSTITUENT RECORD IS UPDATED TO INCLUDE THIS INFORMATION, FACILITATING PERIODIC QUERIES, AS NECESSARY. THE MEMBER WITH A CONFLICT MUST IDENTIFY THE CONFLICT AT ANY BOARD MEETING WHERE THE CONFLICT IS RELEVENT. THE MEMBER CANNOT BE PRESENT AT ANY PART OF THE MEETING WHERE THE RELEVENT TOPIC IS DISCUSSED OR VOTED ON. THE MEMBER CANNOT BE COUNTED FOR A QUORUM. FORM 990, PART VI, SECTION B, LINE 15A & 15B MERCER CONDUCTED THE COMPENSATION REVIEW FOR CEO AND EXECUTIVES IN FEBRUARY AND MARCH 2023. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION HAS A FORMAL POLICY FOR PUBLIC DISCLOSURE AND INSPECTION OF DOCUMENTS. THE POLICY IS POSTED ON THE ORGANIZATION'S WEBSITE. FORM 990, PART III, LINE 4D, OTHER PROGRAM SERVICES GOVERNMENT AFFAIRS AND ADVOCACY - WE DRIVE LEGISLATIVE SUPPORT FOR INCREASED FEDERAL RESEARCH FUNDING FOR PANCREATIC CANCER. OUR GRASSROOTS ADVOCACY EFFORTS LED TO THE PASSAGE OF THE RECALCITRANT CANCER RESEARCH ACT, INCREASED RESEARCH DOLLARS FOR PANCREATIC CANCER AT THE NATIONAL CANCER INSTITUTE, AND LED TO A NEW PANCREATIC CANCER RESEARCH PROGRAM AT THE DEPARTMENT OF DEFENSE. SINCE OUR FOUNDING, FEDERAL RESEARCH FUNDING FOR PANCREATIC CANCER HAS INCREASED BY 900 PERCENT AND CONTINUES TO INCREASE EACH YEAR DUE TO OUR EFFORTS. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD COMPENSATION COMMITTEE IS RESPONSIBLE FOR THE ANNUAL REVIEW AND APPROVAL OF THE COMPENSATION FOR TOP-LEVEL EXECUTIVE MANAGEMENT, OFFICERS, AND KEY EMPLOYEES. THE CHIEF PEOPLE OFFICER STAYS ABREAST OF INDUSTRY SALARY LEVELS AND ALERTS THE COMMITTEE TO ANY CHANGE IN SALARY LEVELS. INDEPENDENT PROFESSIONAL EXPERTS ARE CALLED UPON FOR HIGHER-LEVEL POSITIONS AND ASSIST IN ESTABLISHING EXECUTIVE SALARIES IN THE COMPETITIVE MARKETPLACE. SALARIES IN BOTH FOR-PROFIT AND NOT-FOR-PROFIT ORGANIZATIONS ARE EVALUATED IN ORDER TO ATTRACT THE MOST TALENTED PERSONNEL. INFORMATION IS GATHERED, ANALYZED AND REPORTED TO THE COMMITTEE PRIOR TO THEIR MEETINGS ON COMPENSATION WITH THE INTENT OF ENSURING THAT THE EXECUTIVE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE REVIEW INCLUDES INCENTIVE PLANS AND ALL FRINGE BENEFITS AS WELL AS BASE SALARY ARRANGEMENTS. THE BOARD ESTABLISHES THE CEO/PRESIDENT SALARY LEVEL DURING THE EXECUTIVE SESSION OF A CALLED BOARD MEETING. ONCE APPROVED, EXECUTIVE COMPENSATION PACKAGES ARE FORMALIZED IN WRITING AND, ONCE ACCEPTED BY THE EXECUTIVE, RETAINED IN THE PERSONNEL FILE(S). FORM 990 PART VI, LINE 10B: LOCAL CHAPTERS, BRANCHES, OR AFFILIATES COMPANY AFFILIATES CONSIST OF VOLUNTEERS WHO AGREE TO PERFORM THEIR VOLUNTEER ACTIVITIES IN COMPLIANCE WITH GUIDELINES PROVIDED IN A COMMUNITY ENGAGEMENT AFFILIATE AGREEMENT. THERE ARE NO NON-VOLUNTEER AFFILIATES, CHAPTERS OR BRANCHES (E.G., NO LEGAL ENTITIES). FORM 990 PART IX LINE 11G DESCRIPTION:RESEARCH FEES TOTAL FEES:27220795 FORM 990 PART IX LINE 11G DESCRIPTION:STAFF SUPPORT TOTAL FEES:282910